Varian, a Siemens Healthineers company, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for new functionality on its Ethos therapy system.
The latest iteration of Ethos features a streamlined workflow for daily treatment adaptation across more areas of the body and provides greater connectivity to patient data, according to the vendor. The goal is to make adaptive, personalized radiotherapy implementation easier, Varian said.
Other features include improved algorithms that power the Ethos Intelligent Optimization Engine, images from the HyperSight software being integrated into Ethos, 70-plus structures in various parts of the body, and data sharing with the Aria Core oncology management software for patient management, according to Varian.
